Deep Track Capital, LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
69
Total Value
3088173822
Accession Number
0001856083-25-000002
Form Type
13F-HR
Manager Name
Deep Track Capital, LP
Data Enrichment
93% identified
64 identified5 unidentified

Holdings

69 positions
Manager:
Search and click to pin securities to the top
Page 2 of 4
Dianthus Therapeutics, Inc. /DE/
Shares:
2357702
Value:
$42.8B
Immunocore Holdings plc
Shares:
1411402(+171.7%)
Value:
$41.9B(+173.3%)
Celldex Therapeutics, Inc.
Shares:
2000000(+29.9%)
Value:
$36.3B(-6.7%)
578784100
Shares:
3269126
Value:
$36.0B
AMGEN INC
Shares:
113035
Value:
$35.2B
Xenon Pharmaceuticals Inc.
Shares:
1000000(+491.3%)
Value:
$33.5B(+406.0%)
Edgewise Therapeutics, Inc.
Shares:
1400000(+97.1%)
Value:
$30.8B(+62.4%)
59267L107
Shares:
1094408
Value:
$29.8B
Vaxcyte, Inc.
Shares:
750000
Value:
$28.3B
Autolus Therapeutics plc
Shares:
17849482(+25.5%)
Value:
$27.7B(-17.2%)
Bicara Therapeutics Inc.
Shares:
2000000(+0.0%)
Value:
$26.1B(-25.2%)
COMPASS Pathways plc
Shares:
8859648
Value:
$25.3B
Tectonic Therapeutic, Inc.
Shares:
1401938
Value:
$24.8B
Abivax S.A.
Shares:
3579209(+0.0%)
Value:
$22.4B(-14.6%)
MBX Biosciences, Inc.
Shares:
3018935(+0.0%)
Value:
$22.3B(-60.0%)
GH Research PLC
Shares:
2000000
Value:
$22.1B
Dyne Therapeutics, Inc.
Shares:
2000000(+0.0%)
Value:
$20.9B(-55.6%)
29286M105
Shares:
4557575(+0.0%)
Value:
$20.4B(-32.6%)
INSMED Inc
Shares:
254751
Value:
$19.4B
GALAPAGOS NV
Shares:
741068(-5.1%)
Value:
$18.6B(-13.3%)